Table 2 Relative expression level of miRNAs in paired urine, serum, cervical scrapes, and tissue biopsies.
Sample | Pathology | miR-21-5p (FC ± SE) | P value | miR-145-5p (FC ± SE) | P value | miR-218-5p (FC ± SE) | P value | miR-34a-5p (FC ± SE) | P value | miR-155-5p (FC ± SE) | P value | miR-199a-5p (FC ± SE) | P value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Urine (n = 150) a | Pre-cancer (n = 50) | 1.93 ± 0.9 |  < 0.0001 | 0.32 ± 0.1 |  < 0.0002 | 0.43 ± 0.1 |  < 0.0003 | 0.41 ± 0.1 |  < 0.0001 | 1.89 ± 0.2 |  < 0.0001 | 1.51 ± 0.3 |  < 0.0001 |
Cancer (n = 50) | 2.42 ± 0.1 |  < 0.0001 | 0.24 ± 0.5 |  < 0.0002 | 0.32 ± 0.4 |  < 0.0001 | 0.36 ± 0.2 |  < 0.0001 | 2.27 ± 0.20 |  < 0.0001 | 1.73 ± 0.1 |  < 0.0001 | |
Serum (n = 150) a | Pre-cancer (n = 50) | 2.10 ± 0.20 |  < 0.0001 | 0.15 ± 0.01 |  < 0.0001 | 0.34 ± 0.09 |  < 0.0001 | 0.27 ± 0.2 |  < 0.0001 | 1.72 ± 0.1 |  < 0.0001 | 1.81 ± 0.2 |  < 0.0001 |
Cancer (n = 50) | 2.72 ± 0.2 |  < 0.012 | 0.18 ± 0.01 |  < 0.0001 | 0.26 ± 0.03 |  < 0.008 | 0.21 ± 0.10 |  < 0.0001 | 2.16 ± 0.3 |  < 0.0001 | 1.92 ± 0.2 |  < 0.0001 | |
Scrape (n = 90) b | Pre-cancer (n = 50) | 2.3 ± 0.1 |  < 0.0001 | 0.13 ± 0.1 |  < 0.0001 | 0.28 ± 0.02 |  < 0.0001 | 0.23 ± 0.01 |  < 0.0001 | 1.94 ± 0.2 |  < 0.0001 | 2.02 ± 0.3 |  < 0.0001 |
Tissue biopsy (n = 70) c | Cancer (n = 40) | 3.43 ± 0.3 |  < 0.0001 | 0.12 ± 0.2 |  < 0.0001 | 0.13 ± 0.2 |  < 0.0001 | 0.14 ± 0.2 |  < 0.0001 | 2.6 ± 0.4 |  < 0.0001 | 2.2 ± 0.3 |  < 0.0001 |